Myofascial Acoustic Compression Therapy (MyACT) uses focused acoustic waves to compress and manipulate tissue at varying depths, providing a deep‑tissue massage. The mechanical stimulus increases circulation, reduces pain, and supports the body’s natural healing process.
Developed by Richard Wolf (the leader in lithotripsy), the Piezowave 2 device delivers thousands of high‑energy sound‑wave impulses to the affected tissue. The impulses create micro‑trauma that triggers a healthy inflammatory response, stimulating metabolism, collagen production, and tissue repair.
The system pinpoints the exact injury site and delivers focused pulses only where they are needed—no pain or discomfort in healthy tissue.
Piezowave 2 offers a powerful alternative to injections and surgery for a wide range of conditions, including chronic tendon, ligament, muscle, and joint injuries, as well as post‑surgical rehabilitation.
Session length: 5–10 minutes (≈ 2 000–3 000 pulse waves).
Typical course: 6 sessions on average, spaced 5–10 days apart.
Expected outcomes:
Unlike ultrasound, Piezowave 2 does not generate heat; it creates mechanical pressure that initiates a therapeutic inflammatory response. This makes it suitable for post‑surgical patients and deeper trigger‑point therapy.
Safety: 100 % non‑invasive, no anesthesia, no downtime.